Erica Wood

Associate Professor Wood is a Transfusion Medicine Specialist, and Head of the Transfusion Research Unit at DEPM.  Erica works as a Consultant Haematologist at Monash Health and holds an honorary Consultant Haematologist appointment at Peter MacCallum Cancer Centre/Victorian Comprehensive Cancer Centre.

Erica is a member of the World Health Organization's Expert Advisory Panel on Transfusion Medicine, and has served as a WHO regional advisor in blood safety.  She is President-elect and member of the Board of the International Society of Blood Transfusion and a member of several working parties, including clinical practice, haemovigilance and transfusion-transmitted infections.  Erica is the current President of the International Haemovigilance Network, promoting haemovigilance world-wide and supporting haemovigilance systems in their work.  

Erica is a past President of the Australian and New Zealand Society of Blood Transfusion and in 2016, delivered the Ruth Sanger Oration at the Society's Annual Scientific Meeting - the Society's highest honour.

Between 2012 and 2015 Erica served as Chief Examiner in Haematology for the Royal College of Pathologists of Australasia, and she was Associate Chief Examiner from 2008-2012.  

Erica is a founding member of 'Blood Matters', a Victorian Department of Health transfusion practice improvement collaborative, and between 2016-2013 she chaired its Serious Transfusion Incident Reporting (STIR) haemovigilance program.  

In 2013 Erica was awarded a Churchill Fellowship to support her work in patient blood management practice and research. 

The Transfusion Research Unit (TRU) at Monash University operates a number of regional and national registries to evaluate clinical practice and patient outcomes for important blood disorders, including massive transfusion, aplastic anaemia, fetomaternal alloimmune thrombocytopenia (FMAIT), haemoglobinopathies (thalassaemia and sickle cell disease), thrombotic thrombocytopenic purpura (TTP), lymphoma and myeloma.  The TRU also performs clinical trials, systematic reviews, health economics analyses and a number of other research and teaching activities across the spectrum of blood diseases.